距离 恒瑞医药 打响NewCo模式“*枪”的那笔交易,已过去近两年。两年的时间,足以让一个模式从试水、被审视的状态,进入另一种评估维度。如今,NewCo从行业新词、变为实实在在的资本故事,*批NewCo已经开始有新进展。2025年第四季度,与恒瑞合作的两家NewCo进入关键融资节点:Kailera Therapeutics(前Hercules)完成6亿美元B轮融资,Braveheart也筹集...
Source Link距离 恒瑞医药 打响NewCo模式“*枪”的那笔交易,已过去近两年。两年的时间,足以让一个模式从试水、被审视的状态,进入另一种评估维度。如今,NewCo从行业新词、变为实实在在的资本故事,*批NewCo已经开始有新进展。2025年第四季度,与恒瑞合作的两家NewCo进入关键融资节点:Kailera Therapeutics(前Hercules)完成6亿美元B轮融资,Braveheart也筹集...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.